Patna has witnessed a major breakthrough in the field of pain management and orthopaedic care as renowned pain specialist Dr.

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...

Everyone has probably sometimes heard a popping or clicking sound coming from their knee. Walking regularly, getting down on ...

The degenerative condition sees the protective cartilage in the joint wear down, causing pain, stiffness and swelling.

This new knee treatment, led by researcher Kaitlin Carrato and her team, was shared at a major medical meeting called the ...

Retatrutide, Eli Lilly’s triple-hormone obesity drug, delivers up to 28.7% weight loss and major knee pain relief in ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Retatrutide treatment resulted in significant improvements in WOMAC pain scores and body weight compared with placebo in the TRIUMPH-4 trial.

Eli Lilly drug candidate retatrutide achieved up to 28.7% weight loss and reduced knee osteoarthritis pain in a phase 3 trial of 445 adults.

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

Professional organizations such as the American College of Rheumatology and the American Academy of Orthopaedic Surgeons strongly recommend exercise and other conservative modalities of care prior to ...